Skip to main content
. 2021 Aug 5;13(8):1543. doi: 10.3390/v13081543

Figure 1.

Figure 1

Flowchart of the PHAGEFORCE study. Patients are screened for eligibility by the CBL. Based on the availability of active phages, the patient can (phage treatment group) or cannot (control group) be treated with phage therapy. Regardless of which group the patient is in, all data related to the infection will be collected. CBL: Coordination group for Bacteriophage therapy Leuven; QAMH: Queen Astrid Military Hospital.